Loxo Oncology Inc. (LOXO): OrbiMed Advisors Reports Percentage of Ownership Change
Samuel Isaly’s OrbiMed Advisors recently filed a 13D filing with the SEC in which it reported owning 2.18 million common shares of Loxo Oncology Inc.
Posts Tagged ‘Samuel Isaly’
Selecta Biosciences Inc (SELB): OrbiMed Advisors Reports New Stake
Samuel Isaly’s Orbimed Advisors recently filed a Form 13D with the Securities and Exchange Commission, in which it reported a new stake in Selecta Biosciences Inc (NASDAQ:SELB...
Healthcare Investor Sam Isaly Was Wrong About These 2 Stocks; Makes a Lot of Money on Freshly-Acquired Insurer
OrbiMed Advisors LLC is the world’s largest healthcare-focused investment firm, managing roughly $15 billion in net assets under management.
Affimed NV (AFMD): Samuel Isaly Unloads Shares of Sinking Stock
Affimed NV (NASDAQ:AFMD) is the subject of a 13D filing from Samuel Isaly's OrbiMed Advisors, which shows that the investment firm has sold off some of its stake in the company...
A Look At Three Activist Moves By Several Elite Hedge Funds
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared with 291 recorded a year...
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman.
Hedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks
It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities and Exchange Commission.
These Two Healthcare Stocks Receive A Vote Of Confidence From Elite Hedge Fund Managers
As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that are trading on the cheap...
Samuel Isaly’s New Healthcare Positions: Community Health Systems (CYH), Glaukos Corp (GKOS), More
Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management.
Aisling Capital and OrbiMed Advisors See Value in This Canadian Pharmaceutical Company, Disclosing New Positions
Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new filings with the U.S.
Samuel Isaly’s OrbiMed Advisors Discloses Large Stake in Glaukos Corp (GKOS) After Its IPO
Glaukos Corp (NYSE:GKOS) is an $870 million developer of products for the treatment of glaucoma, which conducted its IPO last week with 6.90 million shares at $18.00 per unit.
Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr.
Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc: Billionaire Halvorsen’s Top 3 Picks
Andreas Halvorsen’s Viking Global disclosed its top three picks for the past quarter in a 13F Form filed with the U.S. Securities and Exchange Commission.
Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company
Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working on a novel method of...
Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX).
Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves
Steve Cohen’s Point72 Asset Management has made bullish moves into a pair of medical technology stocks.
Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake
Roberto Mignone’s Bridger Management has amassed a 5.5% stake in Arrowhead Research Corp (NASDAQ:ARWR) according to a 13G filing with the Securities and Exchange Commission ...
Viking Global Trims Position in Illumina Inc (ILMN) But Might Still Be Bullish
According to its latest 13G filing, Andreas Halvorsen’s Viking Global reduced its stake in Illumina Inc (NASDAQ:ILMN) by 461,100 shares.
Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday.
Sientra Inc (SIEN): Orbimed Discloses Major Stake in Newly Public Company
Samuel Isaly's healthcare-focused fund Orbimed Advisors has disclosed a new position in Sientra Inc (NASDAQ:SIEN), a company that just has gone public.
Arrowhead Research Corp (ARWR), ValueVision Media Inc (VVTV): QVT Financial and Cannell Capital Disclose Their Latest Moves
In two recent filings with the Securities and Exchange Commission, Daniel Gold's QVT Financial and J.
XenoPort, Inc. (XNPT) & CareDx Inc (CDNA): Two Life Sciences Stocks That Can Outperform
Julian Baker and Felix Baker’s Baker Bros. Advisors is tightening its grip over XenoPort, Inc. (NASDAQ:XNPT) and so is James E.
FuelCell Energy Inc (FCEL), Portola Pharmaceuticals Inc (PTLA) & Vector Group Ltd (VGR): 3 Recent Insider Purchases
FuelCell Energy Inc (NASDAQ:FCEL), Portola Pharmaceuticals Inc (NASDAQ:PTLA) and Vector Group Ltd (NYSE:VGR) are three companies from diverse industry sectors that have recently...
VIRGINIA NATL BNK (VABK), Alimera Sciences Inc (ALIM), Advanced Photonix, Inc. (API): Hedge Funds Disclose Moves In Their Equity Portfolios
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential ...
Altisource Asset Management Corp (AAMC), Affimed Therapeutics BV (AFMD): Orbimed Advisors and Luxor Capital Group Are Bullish on These Companies
Altisource Asset Management Corp (NYSEMKT:AAMC) and Affimed Therapeutics BV (NASDAQ:AFMD) felt hedge funds’ bullishness lately.
Relypsa Inc (RLYP): Orbimed Advisors Trims Its Exposure to the Company
As a new filing with the Securities and Exchange Commission showed today, Samuel Isaly's Orbimed Advisors have trimmed its exposure to Relypsa Inc (NASDAQ:RLYP).
Charter Communications, Inc. (CHTR), Intuitive Surgical, Inc. (ISRG), Barrick Gold Corporation (USA) (ABX): Slate Path Capital Top Three Picks
Slate Path Capital, managed by David Greenspan, recently filed its 13F with the U.S. Securities and Exchange Commission.
InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).
Walgreen Company (WAG), llumina Inc. (ILMN), Valeant Pharmaceuticals Intl Inc (VRX): Billionaire Andreas Halvorsen’s Top Stock Picks
Andreas Halvorsen’s Viking Global recently disclosed its long equity positions for the second quarter of 2014. The fund declared holdings worth more than $22.9 billion.
Cognizant Technology Solutions Corp (CTSH), Titan International Inc. (TWI), Salix Pharmaceuticals Ltd. (SLXP) Among Stocks Hedge Funds Are Bullish On
Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in their equity positions.
Loxo Oncology Inc (LOXO): Deerfield Management Discloses 13.65% Activist Stake
Samuel Isaly's Orbimed Advisors has disclosed holding a stake in Loxo Oncology Inc (NASDAQ:LOXO).
Deepak Gulati’s Argentiere Capital’s Top Stock Picks
Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr.
Bill Ackman’s Pershing Square Settles Litigation With Allergan Inc. (AGN)
Pershing Square, managed by Bill Ackman, revealed in a new filing with the U.S. Securities and Exchange Commission that it has settled a lawsuit with Allergan Inc. (NYSE:AGN).
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options.
Pine River Capital Management’s Top Bullish Moves During the First Quarter
A few days ago, Brian Taylor’s Pine River Capital Management, disclosed its equity positions at the U.S. Securities and Exchange Commission.
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at $320 a piece, according...
Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio
In a couple of new filings with the SEC, Hal Mintz's Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ:BLRX) and Recro Pharma Inc...
Viking Global Boosts Its Stake in Illumina, Inc. (ILMN)
According to a new filing with the Securities and Exchange Commission, Andreas Halvorsen’s fund Viking Global, has upped its position in Illumina, Inc.
Broadfin Capital Initiates Stake in Pernix Therapeutics (PTX)
Last night, Broadfin Capital, a healthcare focused hedge fund managed by Kevin Kotler, disclosed in a Securities and Exchange Commission filing that it has initiated a 3.5 million...
Samuel Isaly Says He Is Fond of Regeneron Pharmaceuticals Inc (REGN) & InterMune Inc (ITMN)
Samuel Isaly's Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on CNBC, Mr.
Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock
On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report at the U.S.
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)
Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund...
Orbimed Advisors Discloses 33.5% stake in Relypsa Inc (RLYP)
Sam Isaly’s Orbimed Advisors disclosed holding a 33.5% stake in Relypsa Inc (NASDAQ:RLYP), a company which recently conducted its Initial Public Offering.
Samuel Isaly, Orbimed Advisors Disclose Position in Post-IPO Relypsa
Sam Isaly’s Orbimed Advisors disclosed its position in Relypsa Inc (NASDAQ:RLYP), a company that recently conducted its IPO.
Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical
Samuel Isaly's hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier.
Orbimed Follows Baker Bros and Buys Some Mirati Therapeutics Shares
Orbimed Advisors, a fund focused on the healthcare sector, led by Samuel Isaly, disclosed minutes ago purchasing 125,000 shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX).
